Company / Total Assets
NEUROONE MEDICAL TECHNOLOGIES Corp Total Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$10.8M
FY2025
5-year range
$4.8M / $12.8M
FY2021-FY2025
Trend
+100.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $11M.
Based on SEC 10-K filings.
$11M in FY2025 with a 10-year CAGR of +138.1%.
Improved from $8M to $11M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -5.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- +138.1%
Key checks
Key Insights
- 3-year CAGR of -5.6%, indicating a declining trend.
- In FY2025, total assets increased 100.9% year-over-year.
- Peak total assets was recorded in FY2022.
- Lowest total assets in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.8M | +100.9% |
| FY2024 | $5.4M | -33.7% |
| FY2023 | $8.1M | -36.9% |
| FY2022 | $12.8M | +169.4% |
| FY2021 | $4.8M | +111187.7% |
| FY2016 | $4.3K | +132.7% |
| FY2015 | $1.8K | +796.6% |
| FY2014 | $205 | -81.7% |
| FY2012 | $1.1K | -91.9% |
| FY2011 | $13.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026